Turkish drugmaker Er-Kim has signed a distribution agreement with Germany’s MEDICE Health Family to commercialize Vafseo ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Vafseo ® (vadadustat) is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to treat anemia due ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.

The drug candidate is a new chemical entity. The drug candidate is administered by oral route and targets prolyl-tRNA synthetase (PRS). It was also under development for lung and pancreatic cancer. It ...

Single items on the COPD Assessment Test were associated with different outcomes for smokers versus nonsmokers, which could offer more granular insight. The COPD Assessment Test (CAT), widely ...

The serum combines this magical enzyme with world-class peptides (M-prolyl Palmitoyl and Tripeptide-56 Acetate), collagen and hyaluronic acid; the moisturiser also contains Japanese blood grass root ...